Squarepoint’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Squarepoint’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-58,464	Closed	-$99K	–	2420
2018 Q3	$99K	Buy	58,464 +17,413	+42%	+$31.2K	﹤0.01%	1888
2018 Q2	$71K	Buy	+41,051	New	+$71K	﹤0.01%	1672
2018 Q1	–	Sell	-181,127	Closed	-$404K	–	2415
2017 Q4	$404K	Buy	+181,127	New	+$450K	0.01%	1325
2017 Q1	–	Sell	-122,788	Closed	-$748K	–	2115
2016 Q4	$748K	Buy	122,788 +103,388	+533%	+$540K	0.03%	618
2016 Q3	$107K	Buy	+19,400	New	+$90.8K	0.01%	948
2016 Q1	–	Sell	-66,500	Closed	-$377K	–	1588
2015 Q4	$377K	Buy	+66,500	New	+$405K	0.04%	692

Other funds holding SGYP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

OCM

Opti Capital Management New York $1.64B AUM 0% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Squarepoint's SGYP Position: Q4 2018 in Review

Squarepoint sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q4 2018, closing a stake of 58,464 shares — an estimated $99K sold.

Squarepoint first reported a position in SGYP in Q4 2015 and held it in 6 quarters. The position peaked at $748K in Q4 2016. 89 funds tracked by Wall St. Rank hold SGYP as of Q4 2018.

Squarepoint reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q4 2018 after selling out during the quarter.
Squarepoint sold 58,464 Synergy Pharmaceuticals, Inc Common Stock shares in Q4 2018, an estimated $99K.
Squarepoint first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q4 2015 and held it in 6 quarters.
Squarepoint's Synergy Pharmaceuticals, Inc Common Stock position peaked at $748K in Q4 2016.
89 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2018.

Based on Squarepoint's 13F filing for Q4 2018, filed 14 Feb 2019.